We're always out and about

ABOUT AFLURIA® INFLUENZA VACCINE

Most people today lead very busy lives. Whether it’s going to school or work,
taking care of a family, or staying active outdoors and in the community,
there’s no time in a packed schedule to be sick. And really, who wants to be
sick anyway? Afluria is available in two different formulations. Afluria Quadrivalent, which helps protect against 4 common types of flu viruses, and Afluria, which helps protect against 3 types.1,2

Ask your doctor or pharmacist if Afluria is right for you1

Healthcare professionals have trusted Afluria to help protect people from the flu since the trivalent formulation was introduced in 2007.2 Afluria Quadrivalent and Afluria are made by Seqirus, a company committed to reducing the risk of and treating influenza. Both vaccines are available in preservative-free form; ask your doctor or pharmacist for more information.1,2

Who can get Afluria?

Both Afluria Quadrivalent and Afluria are indicated for use in people 5 years of age and older.1,2*

Almost everyone 5 years of age and older can get Afluria Quadrivalent or Afluria. If you are allergic to eggs and egg protein or any of the ingredients in the vaccine, or if you have had an allergic reaction to a flu shot in the past, you should talk to your doctor before getting either. If you are unsure, ask your doctor or pharmacist if Afluria Quadrivalent or Afluria is right for you.1,2

* The Advisory Committee on Immunization Practices recommends that Afluria not be used in children less than 5 years of age because of this age group’s increased risk of febrile reactions with CSL’s 2010 Southern Hemisphere flu vaccine.1-3

Where can I get Afluria?

Afluria Quadrivalent and Afluria are available at doctors’ offices and many pharmacies. Call ahead to be sure your doctor or pharmacy offers the vaccine you prefer.

Needle-Free option

Afluria Quadrivalent and Afluria are the only flu vaccines approved by the U.S. Food and Drug Administration (FDA) to be given without a needle, using the PharmaJet® Stratis® Needle‐Free Injector.4

PharmaJet Stratis Needle-Free Injector The device uses a stream
of fluid that goes through
your skin in about a tenth
of a second. This method is
proven to provide the same
degree of flu protection as
a shot that is given with
a needle.5,6

Anyone 18 through 64 years of age who can get Afluria Quadrivalent or Afluria may ask for a needle-free version.1,2

Check with your doctor’s office or call your local pharmacy
to be sure they carry the PharmaJet Stratis Needle‐Free
Injector for use only with Afluria. Don’t let a fear of needles
keep you from getting your flu shot this year.

References: 1. Afluria Quadrivalent [package insert]. Summit, NJ: Seqirus USA Inc; 2017. 2. Afluria [package insert]. Summit, NJ: Seqirus USA Inc; 2017. 3. CDC. Prevention and control of seasonal influenza with vaccines: Recommendations of the advisory committee on immunization practices — United States, 2017–18 influenza season. https://www.cdc.gov/mmwr/volumes/66/rr/rr6602a1.htm. Updated August 24, 2017. Accessed September 10, 2017. 4. Seqirus receives FDA approval of Afluria® Quadrivalent (Influenza Vaccine) for people five years of age and older in the US. [press release]. Cambridge, MASS: Seqirus USA Inc.; September 5, 2017. 5. McAllister L, Anderson J, Werth K, et al. Needle free jet injection for administration of influenza vaccine: a randomised non-inferiority trial. Lancet. 2014;384(9944):674-681. 6. Stratis® needle-free injection. PharmaJet® Stratis® Needle-Free Injector Web site. http://pharmajet.com/wp-content/uploads/2016/03/60-10369-001RevA_Stratis-Product-Sheet.pdf. Accessed September 14, 2017.

KEEP THE FLU OFF YOUR SCHEDULE. TALK TO YOUR DOCTOR OR PHARMACIST ABOUT GETTING AFLURIA.

seqirus

The product information presented on this site is for U.S. residents only. Afluria® Quadrivalent, Afluria®, and Seqirus are trademarks of Seqirus UK Limited or its affiliates. PharmaJet® and Stratis® are registered trademarks of PharmaJet Inc. Manufactured by: Seqirus Pty Ltd Parkville, Victoria, 3052, Australia Distributed by: Seqirus USA Inc. 25 Deforest Avenue, Summit, NJ 07901, USA © 2018 Seqirus USA Inc. www.seqirus-us.com MCC Code, Month 2018

AFLURIA® QUADRIVALENT (INFLUENZA VACCINE) IMPORTANT SAFETY INFORMATION FOR CONSUMERS

What is Afluria® Quadrivalent Influenza Vaccine?

Afluria Quadrivalent is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine. Afluria Quadrivalent cannot give you the flu. It stimulates the immune system to produce antibodies that can help to protect against influenza; the full effect of the vaccine is generally achieved approximately three weeks after receiving your vaccination. Annual vaccination is recommended against influenza.

Who should receive Afluria Quadrivalent?

Afluria Quadrivalent is approved for use in persons 5 years of age and older. Afluria Quadrivalent administered by needle and syringe can be used in patients 5 years of age and older. Afluria Quadrivalent can be used with the PharmaJet® Stratis® Needle‐Free Injection System in patients 18 through 64 years of age.

Who should not receive Afluria Quadrivalent?

Do not receive Afluria Quadrivalent if you have an egg allergy. Talk with your doctor if you have ever had a severe allergic reaction after receiving a flu vaccine. Talk with your doctor if you have ever had Guillain‐Barré Syndrome (GBS). Talk with your doctor if you get infections easily, are pregnant, or nursing.

What are the side effects of Afluria Quadrivalent?

The most common injection‐related adverse reactions in children (5 through 8 years of age) administered Afluria Quadrivalent with needle and syringe were pain, redness, and swelling. The most common side effect was headache.

The most common injection‐related adverse reactions in children (9 through 17 years of age) administered Afluria Quadrivalent with needle and syringe were pain, redness, and swelling. The most common side effects were headache, muscle pain, feeling tired and sick.

The most common injection‐related adverse reactions in adults (18 through 64) administered Afluria Quadrivalent with needle and syringe was pain. The most common side effects in adults were headache, muscle pain.

In adults age 65 and older, when administered Afluria Quadrivalent by needle and syringe, the most common injection‐related adverse reactions was pain. The most common side effect was muscle pain.

The most common injection‐related adverse reactions in adults (18 through 64) administered Afluria Quadrivalent by the PharmaJet Stratis Needle‐Free Injection System up to 7 days after vaccination were tenderness, swelling, pain, redness, itching, and bruising. The most common side effects were muscle pain, feeling tired and sick, and headache.

What do I do if I have side effects?

Report any severe or unusual side effects to your healthcare provider.
Please see the full prescribing information for Afluria Quadrivalent for further information.
To report SUSPECTED ADVERSE REACTIONS, contact Seqirus USA Inc. at 1‐855‐358‐8966 or VAERS at 1‐800‐822‐7967 or www.vaers.hhs.gov.

You are also encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088.

Please, see accompanying US full Prescribing Information for AFLURIA QUADRIVALENT. The information provided here is not comprehensive. To learn more, talk about Afluria Quadrivalent with your healthcare provider or pharmacist.

AFLURIA® QUADRIVALENT is a trademark of Seqirus UK Limited and its affiliates. PHARMAJET and STRATIS are trademarks of Pharmajet, Inc.


AFLURIA® (Influenza Vaccine) Important Safety Information for Consumers

What is Afluria® Influenza Vaccine?

Afluria is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine.
Afluria cannot give you the flu. It stimulates the immune system to produce antibodies that can help to protect against influenza; the full effect of the vaccine is generally achieved approximately three weeks after receiving your vaccination. Annual vaccination is recommended against influenza.

Who should receive Afluria?

Afluria administered by needle and syringe can be used in patients 5 years of age and older.
Afluria can be used with the PharmaJet® Stratis® Needle‐Free Injection System in patients 18 through 64 years of age.

Who should not receive Afluria?

Do not receive Afluria if you have an egg allergy. Talk with your doctor if you have ever had a severe allergic reaction after receiving a flu vaccine. Talk with your doctor if you have ever had Guillain‐Barré Syndrome (GBS).
Talk with your doctor if you get infections easily, are pregnant, or nursing.

What are the side effects of Afluria?

Fever side effects were observed in children 5 through 8 years of age in 2010.

The most common injection‐related adverse reactions in children (5 through 17 years of age) administered Afluria with needle and syringe were pain, redness, and swelling. The most common side effects were headache, muscle pain, irritability, feeling tired and sick, and fever.

The most common injection‐related adverse reactions in adults (18 through 64) administered Afluria with needle and syringe were tenderness, pain, swelling, redness, and itching. The most common side effects in adults were muscle aches, headache, and feeling tired and sick.

The most common injection‐related adverse reactions in adults (18 through 64) administered Afluria by the PharmaJet Stratis Needle‐Free Injection System up to 7 days after vaccination were tenderness, swelling, pain, redness, itching, and bruising. The most common side effects were muscle pain, feeling tired and sick, and headache.

In adults age 65 and older, when administered Afluria by needle and syringe, the most common injection‐related adverse reactions were tenderness and pain.

What do I do if I have side effects?

Report any severe or unusual side effects to your healthcare provider. Please see the full prescribing information for Afluria for further information. To report SUSPECTED ADVERSE REACTIONS, contact Seqirus USA Inc. at 1-855-358-8966 or VAERS at 1‐800‐822‐7967 or www.vaers.hhs.gov.

You are also encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088.

The information provided here is not comprehensive. To learn more, talk about Afluria with your healthcare provider or pharmacist. The FDA‐approved product labeling can be found at http://www.afluria.com/prescribing-information.aspx or 1-855-358-8966.

AFLURIA is a registered trademark of Seqirus UK Limited or its affiliates.

PHARMAJET and STRATIS are registered trademarks of PharmaJet.